BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodríguez MJ, Sabaj M, Tolosa G, Herrera Vielma F, Zúñiga MJ, González DR, Zúñiga-Hernández J. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation. Cells 2021;10:3406. [PMID: 34943914 DOI: 10.3390/cells10123406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shan L, Wang F, Zhai D, Meng X, Liu J, Lv X. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis. Biomedicine & Pharmacotherapy 2023;161:114472. [DOI: 10.1016/j.biopha.2023.114472] [Reference Citation Analysis]
2 Wu H, Wang Y, Fu H, Ji L, Li N, Zhang D, Su L, Hu Z. Maresin1 Ameliorates Sepsis-Induced Microglial Neuritis Induced through Blocking TLR4-NF-κ B-NLRP3 Signaling Pathway. JPM 2023;13:534. [DOI: 10.3390/jpm13030534] [Reference Citation Analysis]
3 Wang X, Botchway BOA, Zhang Y, Huang M, Liu X. Maresin1 can be a potential therapeutic target for nerve injury. Biomed Pharmacother 2023;161:114466. [PMID: 36870281 DOI: 10.1016/j.biopha.2023.114466] [Reference Citation Analysis]
4 Alba MM, Ebright B, Hua B, Slarve I, Zhou Y, Jia Y, Louie SG, Stiles BL. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development. Front Physiol 2023;14:1098467. [PMID: 36818443 DOI: 10.3389/fphys.2023.1098467] [Reference Citation Analysis]
5 Qin H, Zhang L, Li M, Liu Y, Sun S, Nie W, Bai B, Li G, Zhang G. EGR1/NOX4 pathway regulates oxidative stress and further facilitates fibrosis progression in keloids responses to TGF-β1. J Dermatol Sci 2022;108:138-45. [PMID: 36608994 DOI: 10.1016/j.jdermsci.2022.12.009] [Reference Citation Analysis]
6 Davinelli S, Medoro A, Intrieri M, Saso L, Scapagnini G, Kang JX. Targeting NRF2-KEAP1 axis by Omega-3 fatty acids and their derivatives: Emerging opportunities against aging and diseases. Free Radic Biol Med 2022;193:736-50. [PMID: 36402440 DOI: 10.1016/j.freeradbiomed.2022.11.017] [Reference Citation Analysis]
7 Hao W, Li M, Cai Q, Wu S, Li X, He Q, Hu Y. Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches. Front Physiol 2022;13:889792. [DOI: 10.3389/fphys.2022.889792] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zúñiga-Hernández J, Sambra V, Echeverría F, Videla LA, Valenzuela R. N-3 PUFAs and their specialized pro-resolving lipid mediators on airway inflammatory response: beneficial effects in the prevention and treatment of respiratory diseases. Food Funct 2022;13:4260-72. [PMID: 35355027 DOI: 10.1039/d1fo03551g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]